Increased transvascular escape rate of albumin during experimental portal and hepatic venous hypertension in the pig. Relation to findings in patients with cirrhosis of the liver

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Increased transvascular escape rate of albumin during experimental portal and hepatic venous hypertension in the pig. Relation to findings in patients with cirrhosis of the liver. / Henriksen, Jens Henrik Sahl; Parving, H H; Christiansen, L; Winkler, K; Lassen, N A.

In: Scandinavian Journal of Clinical & Laboratory Investigation, Vol. 41, No. 3, 1981, p. 289-99.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Henriksen, JHS, Parving, HH, Christiansen, L, Winkler, K & Lassen, NA 1981, 'Increased transvascular escape rate of albumin during experimental portal and hepatic venous hypertension in the pig. Relation to findings in patients with cirrhosis of the liver', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 41, no. 3, pp. 289-99.

APA

Henriksen, J. H. S., Parving, H. H., Christiansen, L., Winkler, K., & Lassen, N. A. (1981). Increased transvascular escape rate of albumin during experimental portal and hepatic venous hypertension in the pig. Relation to findings in patients with cirrhosis of the liver. Scandinavian Journal of Clinical & Laboratory Investigation, 41(3), 289-99.

Vancouver

Henriksen JHS, Parving HH, Christiansen L, Winkler K, Lassen NA. Increased transvascular escape rate of albumin during experimental portal and hepatic venous hypertension in the pig. Relation to findings in patients with cirrhosis of the liver. Scandinavian Journal of Clinical & Laboratory Investigation. 1981;41(3):289-99.

Author

Henriksen, Jens Henrik Sahl ; Parving, H H ; Christiansen, L ; Winkler, K ; Lassen, N A. / Increased transvascular escape rate of albumin during experimental portal and hepatic venous hypertension in the pig. Relation to findings in patients with cirrhosis of the liver. In: Scandinavian Journal of Clinical & Laboratory Investigation. 1981 ; Vol. 41, No. 3. pp. 289-99.

Bibtex

@article{099d68a04e0811df928f000ea68e967b,
title = "Increased transvascular escape rate of albumin during experimental portal and hepatic venous hypertension in the pig. Relation to findings in patients with cirrhosis of the liver",
abstract = "Transvascular escape rate of albumin [TERalb, i.e. the fraction of the intravascular mass of albumin (IVMalb) passing to the extravascular space per unit time] was determined from the disappearance of i.v. injected radioiodinated serum albumin in anaesthetized pigs during control conditions and during regional venous congestion in the infradiaphragmatic area. Balloon catheters were placed in the portal vein (infrahepatic portal congestion) and in the inferior vena cava above (suprahepatic caval congestion) and below (infrahepatic caval congestion) the outlets of the hepatic veins. TERalb was on the average 13% IVMalb.h-1 under basal pressure conditions. TERalb rose significantly (p less than 0.01) during suprahepatic caval and infrahepatic portal congestion to an average of 29 and 19% IVMalb.h-1, respectively. TERalb was positively correlated to the portal pressure (r = 0.75, P less than 0.001). Only a minor increment in TERalb was found during infrahepatic caval congestion. The hepatic share of the increased TERalb during stasis above the hepatic veins was estimated to be threefold that of the extrahepatic splanchnic area. Our results point to filtration of protein, predominantely through the lining of the sinusoids and perisinusoidal space of the liver into the interstitial space around the portal vessels and further into the lymphatics, as the main mechanism of the previously demonstrated marked increase in TERalb in patients with portal venous hypertension due to cirrhosis of the liver.",
author = "Henriksen, {Jens Henrik Sahl} and Parving, {H H} and L Christiansen and K Winkler and Lassen, {N A}",
note = "Keywords: Animals; Biological Transport; Female; Humans; Hypertension; Hypertension, Portal; Kinetics; Liver; Liver Cirrhosis; Portal Vein; Serum Albumin; Swine; Veins; Vena Cava, Inferior; Venous Pressure",
year = "1981",
language = "English",
volume = "41",
pages = "289--99",
journal = "Scandinavian Journal of Clinical & Laboratory Investigation",
issn = "0036-5513",
publisher = "Taylor & Francis",
number = "3",

}

RIS

TY - JOUR

T1 - Increased transvascular escape rate of albumin during experimental portal and hepatic venous hypertension in the pig. Relation to findings in patients with cirrhosis of the liver

AU - Henriksen, Jens Henrik Sahl

AU - Parving, H H

AU - Christiansen, L

AU - Winkler, K

AU - Lassen, N A

N1 - Keywords: Animals; Biological Transport; Female; Humans; Hypertension; Hypertension, Portal; Kinetics; Liver; Liver Cirrhosis; Portal Vein; Serum Albumin; Swine; Veins; Vena Cava, Inferior; Venous Pressure

PY - 1981

Y1 - 1981

N2 - Transvascular escape rate of albumin [TERalb, i.e. the fraction of the intravascular mass of albumin (IVMalb) passing to the extravascular space per unit time] was determined from the disappearance of i.v. injected radioiodinated serum albumin in anaesthetized pigs during control conditions and during regional venous congestion in the infradiaphragmatic area. Balloon catheters were placed in the portal vein (infrahepatic portal congestion) and in the inferior vena cava above (suprahepatic caval congestion) and below (infrahepatic caval congestion) the outlets of the hepatic veins. TERalb was on the average 13% IVMalb.h-1 under basal pressure conditions. TERalb rose significantly (p less than 0.01) during suprahepatic caval and infrahepatic portal congestion to an average of 29 and 19% IVMalb.h-1, respectively. TERalb was positively correlated to the portal pressure (r = 0.75, P less than 0.001). Only a minor increment in TERalb was found during infrahepatic caval congestion. The hepatic share of the increased TERalb during stasis above the hepatic veins was estimated to be threefold that of the extrahepatic splanchnic area. Our results point to filtration of protein, predominantely through the lining of the sinusoids and perisinusoidal space of the liver into the interstitial space around the portal vessels and further into the lymphatics, as the main mechanism of the previously demonstrated marked increase in TERalb in patients with portal venous hypertension due to cirrhosis of the liver.

AB - Transvascular escape rate of albumin [TERalb, i.e. the fraction of the intravascular mass of albumin (IVMalb) passing to the extravascular space per unit time] was determined from the disappearance of i.v. injected radioiodinated serum albumin in anaesthetized pigs during control conditions and during regional venous congestion in the infradiaphragmatic area. Balloon catheters were placed in the portal vein (infrahepatic portal congestion) and in the inferior vena cava above (suprahepatic caval congestion) and below (infrahepatic caval congestion) the outlets of the hepatic veins. TERalb was on the average 13% IVMalb.h-1 under basal pressure conditions. TERalb rose significantly (p less than 0.01) during suprahepatic caval and infrahepatic portal congestion to an average of 29 and 19% IVMalb.h-1, respectively. TERalb was positively correlated to the portal pressure (r = 0.75, P less than 0.001). Only a minor increment in TERalb was found during infrahepatic caval congestion. The hepatic share of the increased TERalb during stasis above the hepatic veins was estimated to be threefold that of the extrahepatic splanchnic area. Our results point to filtration of protein, predominantely through the lining of the sinusoids and perisinusoidal space of the liver into the interstitial space around the portal vessels and further into the lymphatics, as the main mechanism of the previously demonstrated marked increase in TERalb in patients with portal venous hypertension due to cirrhosis of the liver.

M3 - Journal article

C2 - 7313513

VL - 41

SP - 289

EP - 299

JO - Scandinavian Journal of Clinical & Laboratory Investigation

JF - Scandinavian Journal of Clinical & Laboratory Investigation

SN - 0036-5513

IS - 3

ER -

ID: 19398292